BIO-TECHNE Corp SEC Filings
TECHLatest BIO-TECHNE Corp (TECH) SEC filings and EDGAR documents — 8-K current reports, 10-K/10-Q, Form 4 insider trades, with AI summaries.
Hippel James bought 62,068 shares at $47.60 on 2026-07-29; Hippel James sold 51,024 shares at $72.03 on 2026-07-29 (+3 more)
Kelderman Kim bought 35,000 shares at $47.60 on 2026-07-28; Kelderman Kim sold 28,686 shares at $72.07 on 2026-07-28 (+3 more)
Bohnen Shane bought 448 shares at $47.60 on 2026-07-23; Bohnen Shane sold 344 shares at $71.77 on 2026-07-23 (+3 more)
8-K current report
8-K current report
Crouse Steven C. bought 600 shares of Common Stock at $N/A on 2026-06-02; Crouse Steven C. sold 216 shares of Common Stock at $49.77 on 2026-06-02; Crouse Steven C. sold 600 shares of Restricted Stock Units at $N/A on 2026-06-02; Crouse Steven C. transacted N/A shares of Restricted Stock Units at $N/A on N/A; Crouse Steven C. transacted N/A shares of Stock Option (right to buy) at $N/A on N/A
Herr Amy E. bought 6,636 shares of Common Stock at $47.60 on 2026-05-08; Herr Amy E. sold 6,636 shares of Common Stock at $48.28 on 2026-05-08; Herr Amy E. transacted N/A shares of Common Stock at $N/A on N/A; Herr Amy E. sold 6,636 shares of Stock Option (Right to Buy) at $N/A on 2026-05-08; Herr Amy E. transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A
Hippel James bought 62,000 shares of Common Stock at $47.60 on 2026-05-05; Hippel James sold 56,955 shares of Common Stock at $56.68 on 2026-05-05; Hippel James sold 62,000 shares of Stock Options (Right to Buy) at $N/A on 2026-05-05; Hippel James transacted N/A shares of Stock Options (Right to Buy) at $N/A on N/A; Hippel James transacted N/A shares of Performance Restricted Stock Units at $N/A on N/A
Bohnen Shane bought 8,400 shares of Common Stock at $47.60 on 2026-05-05; Bohnen Shane sold 7,055 shares of Common Stock at $56.68 on 2026-05-05; Bohnen Shane sold 8,400 shares of Stock Option (Right to Buy) at $N/A on 2026-05-05; Bohnen Shane transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Bohnen Shane transacted N/A shares of Restricted Stock Units at $N/A on N/A
Kelderman Kim bought 26,692 shares of Common Stock at $47.60 on 2026-05-05; Kelderman Kim sold 23,951 shares of Common Stock at $56.68 on 2026-05-05; Kelderman Kim sold 26,692 shares of Stock Option (Right to Buy) at $N/A on 2026-05-05; Kelderman Kim transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Kelderman Kim transacted N/A shares of Stock Options (Right to Buy) at $N/A on N/A
BIO-TECHNE Corp filed 10-Q on 2026-05-06
8-K current report
Crouse Steven C. bought 794 shares of Common Stock at $N/A on 2026-05-01; Crouse Steven C. sold 311 shares of Common Stock at $55.02 on 2026-05-01; Crouse Steven C. sold 794 shares of Restricted Stock Units at $N/A on 2026-05-01; Crouse Steven C. transacted N/A shares of Restricted Stock Units at $N/A on N/A; Crouse Steven C. transacted N/A shares of Stock Option (right to buy) at $N/A on N/A
Kelderman Kim bought 11,344 shares of Common Stock at $N/A on 2026-04-22; Kelderman Kim sold 1,363 shares of Common Stock at $58.58 on 2026-04-22; Kelderman Kim sold 11,344 shares of Stock Option (Right to Buy) at $N/A on 2026-04-22; Kelderman Kim transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Kelderman Kim transacted N/A shares of Stock Options (Right to Buy) at $N/A on N/A
Hippel James bought 62,000 shares of Common Stock at $N/A on 2026-04-22; Hippel James sold 56,097 shares of Common Stock at $58.58 on 2026-04-22; Hippel James sold 62,000 shares of Stock Options (Right to Buy) at $N/A on 2026-04-22; Hippel James transacted N/A shares of Stock Options (Right to Buy) at $N/A on N/A; Hippel James transacted N/A shares of Performance Restricted Stock Units at $N/A on N/A
Kelderman Kim bought 36,500 shares of Common Stock at $N/A on 2026-04-14; Kelderman Kim sold 32,088 shares of Common Stock at $58.66 on 2026-04-14; Kelderman Kim sold 36,500 shares of Stock Option (Right to Buy) at $N/A on 2026-04-14; Kelderman Kim transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Kelderman Kim transacted N/A shares of Stock Options (Right to Buy) at $N/A on N/A
Bohnen Shane bought 2,259 shares of Common Stock at $N/A on 2026-04-03; Bohnen Shane sold 740 shares of Common Stock at $53.13 on 2026-04-03; Bohnen Shane sold 2,259 shares of Restricted Stock Units at $N/A on 2026-04-03; Bohnen Shane transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Bohnen Shane transacted N/A shares of Restricted Stock Units at $N/A on N/A
Crouse Steven C. transacted N/A shares of Common Stock at $N/A on N/A; Crouse Steven C. bought 2,387 shares of Performance Restricted Stock Units at $N/A on 2026-03-02; Crouse Steven C. bought 735 shares of Restricted Stock Units at $N/A on 2026-03-02; Crouse Steven C. bought 1,911 shares of Stock Option (right to buy) at $N/A on 2026-03-02; Crouse Steven C. transacted N/A shares of Restricted Stock Units at $N/A on N/A
Crouse Steven C. transacted N/A shares of Common Stock at $N/A on N/A; Crouse Steven C. transacted N/A shares of Restricted Stock Units at $N/A on N/A; Crouse Steven C. transacted N/A shares of Stock Option (right to buy) at $N/A on N/A
Herr Amy E. sold 1,976 shares of Common Stock at $59.10 on 2026-02-17; Herr Amy E. transacted N/A shares of Common Stock at $N/A on N/A; Herr Amy E. transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Herr Amy E. transacted N/A shares of Restricted Stock Units at $N/A on N/A